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Abstract
Purpose Long-gap esophageal atresia represents a sig-
nificant challenge for pediatric surgeons and current sur-
gical approaches are associated with significant morbidity.
A tissue-engineered esophagus, comprising cells seeded
onto a scaffold, represents a therapeutic alternative. In this
study, we aimed to determine the optimal techniques for
isolation and culture of mouse esophageal epithelial cells
and to isolate CD34-positive esophageal epithelial stem
cells from cadaveric mouse specimens.
Methods Primary epithelial cells were isolated from
mouse esophagi by enzymatic dissociation from the
mucosal layer (Dispase, Trypsin/EDTA) using three dif-
ferent protocols. In protocol A, isolated mucosa was
minced and incubated with trypsin once. In protocol B,
intact mucosal sheets underwent two trypsin incubations
yielding a single-cell suspension. In protocol C, intact
mucosa explants were plated epithelial side down. Epi-
thelial cells were cultured on collagen-coated wells.
Results Initial findings showed that Protocol B gave the
best results in terms of yield, viability, and least contami-
nation with different cell types and microbes. Esophageal
epithelial cells isolated using Protocol B were stained for
CD34 and sorted using fluorescence-activated cell sorting
(FACS). Of the total cells sorted, 8.3 % (2–11.3) [%median
(range)] were CD34 positive.
Conclusions Our results demonstrate that mouse esoph-
ageal epithelial cells can be successfully isolated from
fresh mouse esophagi using two consecutive trypsin incu-
bations of intact mucosal sheets. Furthermore, the cells
obtained using this method were successfully stained for
CD34, a putative esophageal epithelial stem cell marker.
Further research into the factors necessary for the suc-
cessful proliferation of CD34 positive stem cell lines is
needed to progress toward clinical application.
Keywords Tissue engineering  Esophagus  Esophageal
stem cells
Introduction
Long-gap esophageal atresia
Esophageal atresia (EA) is a congenital malformation of
the esophagus which presents after birth with a global
incidence of between 1 in 2,500 and 1 in 5,000 live births
[1, 2]. The precise mechanisms of causation of EA remain
unknown; however, its development is thought to have its
origin in endodermal proliferation in the 5th week of
gestation.
Esophageal atresia is associated with tracheo-esopha-
geal fistula (TEF) in almost 90 % of cases and, while the
majority of cases are amenable to surgical anastomosis,
serious complications include leakage from the anastomo-
sis site, gastro-esophageal reflux, and a significant mor-
tality rate [3]. Furthermore, for 10 % of EA cases, simple
surgical anastomosis is not possible due to the presence of
insufficient length in the distal segment of esophagus.
These cases, where a TEF is not present, are known as
long-gap EA and have required the development of new
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surgical approaches to repair, including circular myotomy
[4] or interposition with colonic, gastric, or jejunal seg-
ments [5]. However, the non-mutually exclusive serious
complications of leakage, stricture, and/or gastro-esopha-
geal reflux remain a concern and lead to a mortality rate of
5.2 % [6]. Both EA and long-gap EA present significant
challenges that are not fully addressed with current thera-
peutic options.
Tissue engineering (TE) is a multifaceted branch of
regenerative medicine that combines expertise from cel-
lular biology, molecular biology, and materials science to
produce autologous constructs capable of replacing mal-
formed, malfunctioning, or lost tissues and organs. Owing
to the autologous sourcing of cells, TE addresses many of
the issues which blight allotransplantation, such as the
requirement for long-term immunosuppression and short-
age of available donor organs.
Whole organ TE requires the union of two component
parts, which when harmonized, accurately recreate the
dynamic micro- and macro-environments of an organ
structure, permitting both local function and global inte-
gration into the organism. These two core components are
the patient’s own cells and an artificial synthetic or natural
scaffold, onto which the cells are seeded (Fig. 1). Through
the use of the above principles, TE has a promising
potential to provide a therapeutic alternative to current
surgical solutions for EA.
Tissue engineering has provided patients with autolo-
gous functional replacement tissue for a number of con-
ditions, across a variety of clinical arenas to date [7]. TE
has proven especially fruitful for hollow organs whose
principal function is transit or storage. For example, four
young male patients with traumatic damage to the urethra
underwent urethral reconstruction with tissue-engineered
urethral segments. These segments consisted of synthetic
tubular scaffolds seeded with the patients’ muscle and
epithelial cells. Three months after the surgical procedure,
the four patients had achieved normal urine flow rates and
normal histological structure without strictures in the
reconstructed urethras [8]. Similar success has been
achieved with tissue-engineered trachea, bronchus, blad-
der, and blood vessels [9–12].
In contrast to the success of TE when applied to the
organs described above, tissue-engineered esophageal
constructs have not been applied successfully in the clinical
arena. However, preclinical studies have provided insights
that may soon be translated for clinical use. Much of this
preclinical work has highlighted the importance of the
esophageal mucosal layer in preventing strictures in
transplanted constructs. In an experiment to investigate the
speed of epithelialization and viability of constructs after
in vivo transplantation, Nakase et al. [13] compared seeded
and non-seeded constructs. After 3 weeks, a mature epi-
thelium was observed in the pre-seeded esophageal
implants whereas the non-seeded controls showed reduced
epithelialization and significant stricture formation. Fur-
thermore, in the canine model, Badylak et al. demonstrated
that esophageal constructs which had undergone specific
ablation of the epithelium subsequently developed severe
strictures when introduced into the in vivo environment
[14]. These findings suggest that the luminal esophageal
epithelium plays a key role in maintaining esophageal
patency in both the native and artificial esophagus [15].
Further studies with acellular scaffolds have also
Fig. 1 Esophageal TE requires
the combination of appropriate
scaffolds and cells. Cells used
for repopulation of the epithelial
and muscular layers can be
derived from ESC, iPS, AFSC,
and ASC; ESC embryonic stem
cells, iPS induced pluripotent
stem cells, AFSC amniotic fluid
stem cells, ASC adult stem cells
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reinforced the importance of the extra-luminal muscle layer
of the esophagus for construct function. Yamamoto et al.
[16, 17] transplanted acellular silicone tubes coated in a
collagen ‘sponge’ into nine dogs and found that there was
no infiltration of the construct with muscle cells at all time
points up to a maximum of 26 months.
These findings from preclinical esophageal TE suggest
important roles for both the epithelial cells of the esopha-
gus and the external muscle layer, in recreating the func-
tional esophagus with fidelity. Lack of either or both of
these components appears to severely impair the func-
tionality of constructs.
Isolation of esophageal epithelial cells has been
attempted by several investigators to date; however, due to
the diversity of isolation protocols used there is currently
no single gold standard technique.
Early work focused on allowing cell migration from
esophageal specimens onto cell culture plates following
placement face down (i.e., explant culture) [18]. More
recently, Kalabis et al. [19] have isolated whole mucosal
sheets from Dispase-treated mouse esophagus that were
then trypsinised and minced to obtain a cell suspension.
Saxena et al. [20] used a different approach to isolate and
culture esophageal epithelial cells from the rat. They used
an isolation protocol whereby following overnight Dispase
incubation and mucosal separation, the whole mucosa was
incubated in trypsin–EDTA to dissociate individual cells
[20].
The aim of this paper is to compare three of the most
commonly used techniques for the isolation and effective
culture of esophageal epithelial cells from mouse cadav-
eric specimens. After establishing the most effective
technique of the three, we aim to further this protocol by
isolating esophageal epithelial stem cells by applying
known stem cell markers, principally CD34. The resulting
population of CD34 positive cells represent a potential
source of cells that may have great utility for the future TE
efforts toward a replacement esophagus for patients with
long-gap EA.
Materials and methods
Harvest of organs
All surgical procedures and animal husbandry were carried
out in accordance with UK Home Office guidelines under
the Animals (Scientific Procedures) Act 1986 and the local
ethics committee. Adult C57/Bl-6 mice were euthanized by
CO2 inhalation and cervical dislocation (n = 20). A mid-
line incision was made to completely expose the abdominal
and thoracic cavities. The esophagus was harvested from
the cervical portion to the gastro-esophageal junction and
washed with phosphate buffered solution containing 1 %
solution of antimycotic and antibiotic (PBS/AA; Sigma,
UK).
Cell isolation
Epithelium, protocol A
Freshly isolated mouse esophagi were cut longitudinally to
expose mucosa and rinsed with PBS/AA. Esophagi were
incubated with 1 U/mL Dispase-I (Roche, UK) and 1 %
AA for 15 min at 37 C, following which, the mucosal
sheets were separated from the submucosa and finely
minced using a scalpel (BD Biosciences, UK).The minced
mucosal tissue was incubated with 0.05 % trypsin/EDTA
(Sigma, UK) and 1 % AA at 37 C for 10 min. An equal
volume of 200 lg/mL soybean trypsin inhibitor (Sigma,
UK) was added. The epithelial cell suspension was passed
through 40 lm cell strainer (BD Biosciences, UK), cen-
trifuged at 1,500 rpm for 5 min at 4 C, and the pellet was
resuspended in keratinocyte serum-free medium supple-
mented (K-SFM?; Life Technologies, UK) with 1 ng/mL
Epidermal Growth Factor (EGF; Sigma, UK) 0.4 % Bovine
Pituitary Extract (BPE; Sigma, UK), 2 % Fetal Bovine
Serum (FBS; Sigma, UK) 10 mM HEPES (Sigma, UK)
and 1 % AA. Isolated cells were seeded onto 6-well plates
and maintained at 37 C, 5 % CO2. The plates were either
freshly coated with rat tail collagen I (BD Biosciences,
UK), coated and then air-dried for 24 h or not coated at all.
The medium was changed every 2–3 days and cells were
passaged when they reached 60 % confluence.
Epithelium, protocol B
Freshly isolated mouse esophagi were cut longitudinally
and rinsed with PBS/AA. Esophagi were incubated with
1 U/mL dispase-I and 1 % AA for 15 min at 37 C, fol-
lowing which, the mucosal sheets were separated from the
submucosa, pooled into 1 mL 0.05 % trypsin–EDTA and
1 % AA, incubated at 37 C for 10 min and vortexed for
10 s. The supernatant was removed and pipetted into 8 mL
of soybean trypsin inhibitor (250 lg/mL in PBS). To
examine the need for further isolation, the remaining
mucosa was incubated in another 1 mL trypsin-EDTA and
1 % AA to 37 C for 5 min, and the supernatant added to
8 mL of Soybean trypsin inhibitor. The resulting cell sus-
pensions were filtered separately through a 40 lm cell
strainer and centrifuged at 188g for 5 min at 4 C. The
pellets were resuspended in K-SFM? medium. Isolated
cells were seeded onto 6-well collagen-coated plates and
maintained at 37 C, 5 % CO2. The medium was changed
every 2–3 days and cells were passaged when they reached
60 % confluence.
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Epithelium, protocol C
Freshly isolated mouse esophagi were cut longitudinally to
expose mucosa and rinsed with PBS/AA. Esophagi were
incubated with 1 U/mL Dispase-I and 1 % AA for 15 min
at 37 C, following which, the mucosal sheets were sepa-
rated from the submucosa and incubated with 0.05 %
trypsin/EDTA and 1 % AA at 37 C for 10 min. Following
the trypsin treatment, mucosal sheets were placed into
HBSS (Sigma, UK) and 1 % AA, and cut into 5 mm seg-
ments using a sterile scalpel. The segments were placed
mucosal surface face down onto rat tail collagen-1 (BD
Biosciences) coated wells of a 6-well plate. Explants were
left to attach for 20 min, at which point K-SFM? medium
was added to cultures. After 24 h, explants were removed
from the wells. The medium was changed every 2–3 days
and cells were passaged when they reached 60 %
confluence.
Bone marrow
Mouse bone marrow (BM) was isolated from two hind limb
bones of C57/Bl-6 mice. A 27G (BD Biosciences, UK)
1 mL needle syringe was pushed into the bone cavity and
the BM was flushed out with 1 mL PBS. The bone marrow
was filtered through a 70 lm cell strainer (BD Biosciences,
UK). The resulting cell suspension was centrifuged at
188g for 5 min at 4C and kept on ice.
Fluorescence-activated cell sorting (FACS)
Primary esophageal epithelial cells were isolated using
the protocol described in ‘‘Epithelium, protocol B’’. Fol-
lowing centrifugation, the cell pellet was resuspended in
200 lL of staining buffer (SB; PBS, pH 7.2, 0.5 % bovine
serum albumin [BSA; Sigma, UK], and 2 mM EDTA).
For the unstained control, 20 lL of the cell suspension
was removed and 80 lL of SB buffer was added to it. The
remaining 180 lL of cell suspension was stained with PE
Rat anti-Mouse CD34 antibody. The cells were stained
using an antibody concentration of 1:100 at 4 C for
30 min. The cells were then washed with 1 ml of SB
buffer and centrifuged at 3009g for 5 min at 4 C. The
cell pellet was resuspended in 500 lL of SB buffer.
Freshly isolated bone marrow cells were used as a positive
control for CD34. Following isolation the pellet was
resuspended in 200 lL of SB buffer, 150 lL of which was
stained with CD34 PE (BM? control), and 50 lL of which
was not stained (BM- control). Staining with the Viap-
robe [7-amino-actinomycin D (7-AAD)] was used to
exclude dead cells. Flow cytometry was performed on a
MoFlo XDP cell sorter.
Immunofluorescence
Cultures were fixed in 4 % paraformaldehyde (PFA) for
15–20 min at room temperature and washed twice (5 min
each) with 1 9 Rinse Buffer [PBS/Tween 20 (0.05 %);
Sigma, UK]. Permeabilization was achieved with 0.1 %
Triton X-100/PBS (Sigma, UK) for 10 min at room tem-
perature (RT). Cultures were washed in PBS for 5 min
three times. Blocking solution (4 % goat serum/PBS;
Sigma, UK) was applied for 30 min at RT. Primary anti-
body incubation was performed using pan-cytokeratin
(Rabbit polyclonal; Abcam, UK) (dilution 1:100) overnight
at 4 C. Cells were washed for 5 min, three times with 1X
Rinse Buffer. Cells were incubated with secondary anti-
body (Alexa-Fluor 488) for 60 min at RT and washed three
times (5 min each) with 1 9 Rinse Buffer. Nuclei were
counterstained with 40,6-diamidino-2-phenylindole (DAPI;
dilution 1:1,000) and Sudan Black was used to quench
autofluorescence. Images were captured using Axio-plot2
Carl Zeiss fluorescence microscope.
CD34? fraction culture
10 9 104 Swiss 3T3 fibroblasts were plated onto each well
of a 6-well plate in DMEM/10 %FBS (Sigma, UK) and
incubated at 37 C, 5 % CO2 for 24 h to allow attachment.
To mitotically inactivate the fibroblasts, medium was
replaced with 2.5 mL of 10 lg/mL Mitomycin C (Sigma,
UK), incubated for 1 h and washed three times with PBS,
following which 2 mL of William’s E medium/20 % FBS
(Invitrogen, UK) was placed in each well. Following
sorting using the MoFlo XDP cell sorter the CD34 positive
fraction was seeded on the mitotically inactivated Swiss
3T3 fibroblast feeder layers.
Rhodamine B colony formation assay
CD34? sorted cells were maintained in culture for
2 weeks, after which medium was removed and 4 %
paraformaldehyde (PFA) was applied to fix the cells. After
10 min at room temperature, cultures were washed with
PBS and colonies were stained with 1 % Rhodamine B
solution, for 20 min, and then washed with water. Colonies
were visualized under light microscopy.
Results
Early experiments focused on optimization of cell isolation
steps that varied greatly across the literature. For example,
bacterial contamination was avoided by supplementing all
protocol steps with 1 % AA. Dispase-I concentration was
tested across the range of 0.1–10 U/mL, with 1 U/mL
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showing the best effect in separating the mucosa while
preserving the overall structure. Medium change following
isolation was shown to allow the attachment of a greater
number of cells if done at 72 h rather than 24 h (data not
shown).
Mouse esophageal epithelial cells were isolated using
protocol A and plated onto either freshly collagen-coated
wells, collagen-coated wells that were air-dried for 24 h, or
wells with no coating. Cells were seen to attach in similar
numbers onto freshly coated and air-dried collagen wells.
Epithelial cell monolayers, with distinctive cobblestone
morphology, were observed in the fresh and dried collagen-
coated wells after 3 weeks, whereas no attachment of cells
was observed in the non-collagen-coated plates (Fig. 2a).
In wells lacking collagen coating spindle-shaped cells were
seen attaching during the first 72 h (Fig. 2a, inset) that
mostly died off by 1 week. Cultures were characterized by
immunofluorescence to ensure true epithelial identity.
Cultures were fixed and stained with anti-mouse pan-
cytokeratin 26 (PCK-26) antibody, with DAPI used as a
fluorescent nuclear counterstain. Epithelial cell cultures on
collagen-coated wells showed positivity for PCK-26
(Fig. 2b). There was very little PCK-26 positivity present
in the non-collagen plate (Fig. 2b). In all isolation with
protocol A, there was significant contamination with
fibroblasts (Fig. 2a, inset).
The isolation and culture of esophageal epithelial cells
using protocol B successfully yielded epithelial cell cul-
tures. Cells were cultured on freshly collagen-coated wells
and epithelial cell colonies were visible within 1 week of
plating, which had resulted in confluent epithelial
monolayer by 2 weeks (Fig. 3). Isolation with the first
trypsin incubation was successful in all experiments (8/8)
and the use of a second trypsin incubation did not isolate
further cells (data not shown).
For protocol C (i.e., explant technique) whole mucosal
sheets were isolated (Fig. 4a) and the mucosal side was
confirmed by observing the mucosal ridges under micro-
scope (Fig. 4b) that were then placed face down on tissue
culture plates coated with collagen. Under a cell culture
microscope, the cells can be seen migrating out of the
mucosal sheet (Fig. 4c, asterisk) and forming the distinc-
tive cobblestone morphology (Fig. 4d).The majority of
explants detached easily from culture plates upon the
addition of medium. Culture outcomes, however, were very
variable. In 33 %, (3/9) of isolations areas of epithelial cell
confluence were identified after 6 days (Fig. 4e). In 67 %,
(6/9) of isolations explant cultures did not generate viable
epithelial cell cultures with differentiated epithelial
squames attaching and many cells remaining unattached
and suspended in the medium (Fig. 4f). In all cases,
there was concomitant migration and attachment of spin-
dle-shaped cells that did not stain positive for PCK-26
(Fig. 4g, h). Immunofluorescence characterization of
explant cultures in general showed weak positivity for
PCK-26 (Fig. 4h).
Esophageal epithelial cells isolated using protocol B
were analyzed by FACS for CD34 positivity, a putative
stem cell marker. Different gates were placed subdividing
Fig. 2 Collagen coating of plates (wet or dried) allowed a higher
number of isolated cells to attach and grow following protocol A as
shown by the light microscopy images (a). In the wells with no
collagen spindle-shaped cells were mostly seen (inset). Pan-cytoker-
atin staining for epithelial cells demonstrated the epithelial identity of
cells seeded onto collagen-coated plates, with no positive staining in
the lack of collagen (b); scale bar 100 lm
Fig. 3 Cells isolated using protocol B showed a characteristic
epithelial cobblestone morphology in culture (a), forming a mono-
layer by 2 weeks (b); scale bar 100 lm
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the fluorescence of positively staining cells into brightly
fluorescent and dimly fluorescent populations. A charac-
teristic FACS sort gate is shown in Fig. 5. An average
mean percentage of the CD34? bright population consti-
tuted 1.6 %, whereas the CD34? Dim population consti-
tuted 9.2 % of total sorted cells (Table 1). The CD34? cells
were directly sorted onto irradiated Swiss 3T3 fibroblasts
and cultured for up to 2 weeks. CD34? dim and bright
subpopulations demonstrated similar growth characteristics
in culture (Fig. 6). Staining with Rhodamine B to check for
colony formation was positive after 2 weeks (Fig. 6,
Rhodamine B).
Discussion
Esophageal TE could provide a vitally needed alternative
for the repair of long-gap EA, which still poses a significant
challenge to pediatric surgeons, and could be used for other
esophageal disease of children and adults. The seeding of
autologous cells onto a decellularized esophageal cadaveric
scaffold could lead to the development of functional
esophageal tissue. A principal requirement to achieve this
is successful isolation and culture of esophageal epithelial
cells. We set out to identify the optimal method for iso-
lating esophageal epithelial cells by comparing and fine-
tuning previously reported protocols. We also assessed
whether collagen-coated plates improve epithelial cell
proliferation in vitro, and finally, we aimed to assess the
possibility of isolating esophageal epithelial stem cells
using CD34 as a stem cell marker.
Fig. 4 In protocol C, whole mucosal sheets were isolated (a), the
mucosal side was identified by the mucosal ridges (b) and plated.
Cells were seen migrating out of the mucosal sheet (c, asterisk) and
acquiring cobblestone morphology (d). In 33 % of isolations,
epithelial colonies were identified after 6 days (e), while 67 % of
isolations were unsuccessful in doing so (f). In all cases, there was
concomitant migration and attachment of spindle-shaped cells that did
not stain positive for PCK-26 (g, h); scale bar 100 lm
Fig. 5 CD34 FACS sorting gates for CD34 dim (*) and bright (**)
populations
Table 1 Percentage of total sorted CD34? cells in each subpopula-
tion; median (range)
Cells CD34? (%)
Esophageal epithelial cells 8.3 (2–11.7)
CD34? bright subpopulation 1.6 (1.1–1.7)
CD34? dim subpopulation 9.2 (4.8–10)
Unstained control 0.05 (0.04–0.06)
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The results of this study show much concordance with
previous efforts in culturing mouse esophageal epithelial
cells. In the rat, Beckstead and colleagues investigated
whether the adhesion of esophageal epithelial cells was
affected by coating of culture wells. They compared groups
of cells cultured in wells coated with collagen I, collagen
IV, fibronectin, laminin, and osteopontin both between
groups and of each group to a non-coated control group
[21]. They found that all of the tested coatings increased
adhesion of cells, while the two collagen groups showed
the highest rates of adhesion. In the mouse model, Kalabis
et al. [19] explored the use of enriched collagen gels
containing esophageal fibroblasts or a dual layer of colla-
gen underneath a collagen–fibroblast–Matrigel composite
[22]. Both of these culture environments used collagen as
part of a 3D organotypic culture system. Similarly, Saxena
et al. [20] cultured esophageal epithelial cells on a pre-
fabricated porcine collagen–elastin scaffold.
Therefore, the results of the present study on the influ-
ence of collagen coating on the adhesion of esophageal
epithelial cells in culture appear to be concordant with the
previous findings of other investigators. Furthermore, on
the question of whether fresh or air-dried collagen coatings
are superior, no significant difference was demonstrated.
Good isolation of epithelial cells was achieved using
both whole esophageal mucosa and minced tissue. How-
ever, the latter technique introduced contamination by
esophageal fibroblasts. This finding may be explained by
considering the mechanical effect of mincing on the
esophageal mucosa; it increases the surface area of the
mucosal tissue, thereby exposing a greater proportion of
intercellular junctions to the dissociative actions of trypsin
and EDTA. Furthermore, it allows the reagents to work on
a greater area of the submucosa, which will allow the
release of more stromal cells when compared to a non-
mincing protocol. For this reason, it is perhaps unsurprising
that mincing introduced a level of fibroblast contamination
that was not seen with trypsinization of whole mucosa.
Although repeating trypsinization was not shown to
increase the isolation of cells from the esophageal mucosa
specimens, the addition of further techniques used in other
investigations may help to increase isolation yield in future
studies. Previous groups have employed a stage of vor-
texing [20, 23] or constant pipetting [21] during the incu-
bation with trypsin to further the disruption of cell–cell
adhesions and thereby to increase the yield of single cells.
The successful application of these additional techniques
will be required to maximize the eventual clinical appli-
cability of the findings described herein.
Culture using mucosal explants (protocol C) showed
variable results with unreliable cell attachment and growth,
along with fibroblast contamination. With consideration
given to the migratory characteristics of fibroblasts, it
appears logical that cultures resulting from the application
of protocol C suffered a certain degree of fibroblast con-
tamination. The results of the present study appear at odds
with a previous application of the explant technique for
culturing esophageal epithelial cells [2], which found
minimal contamination of the cell culture with fibroblasts.
The contrasting results of this previous work on explant
culture may be explained by their use of a rat model;
however, the contribution of this difference in experimental
design cannot be completely quantified.
Cells isolated with protocol B that expressed CD34
produced colonies after 2 weeks in vitro. Our finding that
(both dim and bright) populations of CD34? cells formed
colonies within 2 weeks when cultured on fibroblast feeder
layers provides further support for the role of CD34 as a
putative marker of esophageal epithelial stem cells.
Unexpectedly, both dim and bright populations displayed
Fig. 6 CD34?esophageal epithelial cells were sorted onto mitotically inactivated Swiss 3T3 fibroblasts. Dim and bright subpopulations showed
similar growth characteristics in vitro, with Rhodamine B staining confirming colony formation at 2 weeks; scale bar 100 lm
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similar growth characteristics in culture. This suggests that
further work is necessary to fully elaborate the implications
of CD34 positivity in esophageal epithelial stem cells.
In this study, we have optimized an isolation protocol
for esophageal epithelial cells from mouse tissue. To fur-
ther our work, the protocol needs to be examined in the
human model using small biopsies as a source, to mirror
the process that will need to be followed for clinical
autologous use. Seeding of the isolated epithelial cells on
natural or synthetic scaffolds in bioreactor environments
represents the next step toward a tissue-engineered
esophageal replacement.
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